CLINICAL_TRIALS
trial_result
· 2017-10-12
Clinical Trial Update: Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia [Phase 2, Phase 3]
Summary
A Phase 2/3 trial evaluating intensified conditioning with high-dose etoposide for adults undergoing allogeneic hematopoietic stem cell transplantation for acut…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Lymphoblastic Leukemia, Stem Cell Transplantation, Hematopoietic | Phase 2, Phase 3 | Status: COMPLETED